AMBS
Amarantus Bioscience Holdings, Inc
Other OTC
People also watch:ELTPONCSMSTXIGXTNVIV
0.05-0.00 (-7.07%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.05
Open0.05
Bid0.00 x
Ask0.00 x
52wk Range0.03 - 4.65
Day's Range0.05 - 0.05
Volume494,805
Avg Vol (3m)542,555
As of 3:59 PM EDT. Market closed.
  • Zacks Small Cap Research5 months ago

    AMBS: Update on Diagnostics Business

    On Jan 19, Amarantus (AMBS) and Avant Diagnostics (AVDX) announced they have entered into a Letter of Intent to merge an Amarantus wholly-owned subsidiary, Amarantus Diagnostics, into Avant Diagnostics. Under the terms of the LOI, upon execution of definitive merger agreements, Avant shall issue to Amarantus 80 million shares of common stock of Avant Diagnostics, representing approximately 45% of Avant's post-merger common stock, and 10 million additional shares of common stock upon achievement of certain sales milestones.

  • Zacks Small Cap Research5 months ago

    AMBS: Amarantus Updates its cGMP Manufacturing Technical Transfer

    By Grant Zeng, CFA Earlier this morning (Feb 22), Amarantus (OTCQB: AMBS), provided an update on the status of its cGMP manufacturing technical transfer for producing ESS at Lonza Walkersville, Inc., a ...